Spots Global Cancer Trial Database for Deep sequencIng in Cutaneous Squamous CEll caRciNomas

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Deep sequencIng in Cutaneous Squamous CEll caRciNomas

Official Title: Comprehensive and Deep Profiling in Cutaneous Squamous Cell Carcinomas to Unravel Treatment Efficacy in Immunotherapy Treated Patients

Study ID: NCT05878288

Conditions

Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Neoplasms

Non-melanoma Skin Cancer

Interventions

Cemiplimab

Study Description

Brief Summary: To comprehensively describe the molecular profile of the tumour ecosystem of cutaneous squamous cell carcinoma (CSCC) patients treated with neoadjuvant immunotherapy using single-cell sequencing and bulk genomic profiling.

Detailed Description: The purpose of this study is to comprehensively assess the molecular profile of the tumour ecosystem of CSCC patients who receive immunotherapy in the neoadjuvant curative setting, in order to identify molecular mechanisms facilitating treatment response and resistance and to identify molecular markers for disease monitoring. Patients who receive immunotherapy for the neoadjuvant management of CSCC will be invited to participate in this translational research study during their treatment journey to provide tumour tissue (fresh and formal-fixed paraffin-embedded, FFPE) and blood samples before and after exposure to immunotherapy. This study has primarily a translational research objective with the clinical component conducted as a prospective, single-centre, single-arm, open label study.